Frozen heart fix: new device targets AFib

NCT ID NCT05416086

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a medical device that freezes small areas of heart tissue to treat atrial fibrillation (AFib) and related irregular heartbeats. The goal was to see if the procedure safely stops abnormal rhythms for at least 12 months. The study enrolled 91 people, but was terminated early, so the full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cryoablation procedure using the iCLAS Cryoablation System
What this could lead to
If successful, this could offer a safe and effective way to freeze abnormal heart tissue and restore normal rhythm in people with atrial fibrillation.
What could go wrong
The study was terminated early, so results are limited. Cryoablation carries risks like heart tissue damage or blood clots, and the procedure may not prevent future arrhythmias.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Erasmus MC

    Rotterdam, Netherlands

  • Onze-Lieve-Vrouw Hospital Aalst (OLV)

    Aalst, 9300, Belgium

  • St. Antonius Ziekenhuis

    Nieuwegein, 3435, Netherlands

  • Universitatsklinikum Erlangen

    Erlangen, 91054, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.